Letter to the Centers for Medicare and Medicaid Services on the CY 2023 Medicare Physician Fee Schedule proposed rule in support of expanding colorectal cancer screening coverage.
Letter to Reps. Frank Pallone and Anna Eschoo thanking them for their commitment to improving access to early cancer screening technologies and request for more information from the United States Preventive Services Task Force (USPSTF) on improving their timeliness and transparency.
Letter to the Food and Drug Administration on the Proposed Rule for a Tobacco Product Standard for Menthol Cigarettes (PDF, 706 KB)
Letter to the Food and Drug Administration on the Proposed Rule for a Tobacco Product Standard for Characterizing Flavors in Cigars (PDF, 658 KB)
Letter to Congressional leadership in support of several key policies that would enhance access to, and diversity of, clinical trials.
Letter requesting that the FDA finalize the proposed rules entitled General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard.
Letter to Congressional leaders urging they address the use of synthetic nicotine in e-cigarettes as soon as possible and enact legislation that would give FDA’s Center for Tobacco Products the authority to regulate synthetic nicotine products as tobacco products.
Letter to Congress in support of President Biden’s Cancer Moonshot to “end cancer as we know it” and build and increase investments in discovery, prevention and health disparities.
Letter to President Biden urging him to declare March 2022 as Colorectal Cancer Awareness Month
Letter to President Biden, Vice President Harris and Congressional leadership urging passage of the Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Letter to the National Committee for Quality Assurance regarding the Colorectal Cancer Screening measure being considered for inclusion in the Healthcare Effectiveness Data and Information Set (HEDIS) Measurement Year 2022 Technical Specifications Update
Letter to the Centers for Medicare and Medicaid Services on the CY 2022 Medicare Physician Fee Schedule proposed rule
Letter to MLB and MLBPA to prohibit the use of tobacco products at MLB stadiums
Letter to Senators Carper and Collins in support of the Quit Because of COVID-19 Act
Statement in support of COVID-19 vaccination policy for all health care professionals
Letter to Representatives DeGette and Upton on the 21st Century Cures 2.0 Discussion Draft
Letter to the Departments of Health and Human Services and Treasury on proposed rule impacting access to affordable health care coverage and addressing the needs of cancer patients.
Letter to Congress opposing amendments to weaken FDA’s authority in the FY 2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill.
Letter to Congressional leadership requesting NIH emergency funding for cancer research.
Letter to Congressional leaders requesting FY2022 funding for Consumer Assistance Programs.
The Prevent Cancer Foundation and more than 300 organizations from all 50 states applaud Representative Terri Sewell (D-Ala.) and Senators Mike Crapo (R-Idaho) and Michael Bennet (D-Colo.), who are leading the effort to modernize Medicare and ensure seniors have access to breakthrough cancer screening technology. [News release]
Letter requesting that the FDA finalize the proposed rules entitled General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard.
Letter to FDA urging the agency to prohibit menthol cigarettes and other non-tobacco flavored tobacco products, including e-cigarettes and cigars.
Letter to the Advisory Committee on Immunization Practices (ACIP) urging the acceleration of COVID-19 vaccination to cancer patients and survivors, who are at risk of poor outcomes from COVID-19.
Letter to President Biden urging him to declare March as National Colorectal Cancer Awareness Month.
Letter to the Advisory Committee on Immunization Practices (ACIP) urging further review of the COVID-19 vaccine recommendation schedule to prioritize cancer patients and survivors at higher risk of death from COVID-19.
Letter to the Centers for Medicare & Medicaid Services (CMS) urging them to withdraw the interim final rule that implements a most favored nation (MFN) model in Medicare Part B.
Letter to congressional leadership recommending the inclusion of the Removing Barriers to Colorectal Cancer Screening Act, HR 1570/S 668, in the year end legislative package.
Letter to House and Senate Appropriations Subcommittee requesting prioritization of funding for cancer research and prevention
Letter to FDA to grant pending Citizen Petition and commence a rulemaking for the prohibition of menthol cigarettes
Letter to FDA Calling for Public Disclosure of E-Cig Applications
Letter to HHS Secretary Alex Azar regarding treatment of cancer patients during the COVID-19 Pandemic
Letter to the Hill regarding considerations for cancer patients during the COVID-19 Pandemic
Letter requesting support for personal protective equipment for medical staff
FY2021 Senate Appropriations Comments for DoD Melanoma Research Program
Letter opposing Medicaid block grants
Comments on FDA proposed rule for marketing new tobacco products
Letter to CMS on a National Coverage Determination for Next-Gen Sequencing
Letter of support to Senate leadership regarding the nomination of Dr. Hahn for FDA Commissioner
Comments to CMS on National Coverage Determination for Next Gen Sequencing (NGS)
Consensus statement in support President Trump’s September 2019 proposal to remove all non-tobacco-flavored e-cigarettes, including mint and menthol flavors, from the marketplace
Letter to the city council in support of banning flavored tobacco products in Washington, DC
Comments for final rule on adding graphic warning labels for cigarettes.
Letter of support for menthol cigarette ban provision in the Reversing Youth Tobacco Epidemic Act
Letter urging CMS to End to State Violations of Federal Medicaid Law
Letter to global fund seeking the resources for treatment of HIV/AIDS, TB, Malaria, and Hepatitis together
Letter to CMS on the Date of Service Rule (14-day rule), which led to some physicians waiting 14 days to send test results to allow labs to bill CMS directly
Comments on the Physician Fee Schedule 2020
Comments on the Hospital Outpatient Prospective Payment Program 2020
Letter in support of continued funding for the REACH program
Letter to President Trump and the First Lady on closing the Medicare colonoscopy loophole
Letter of support for confirmation of Dr. Sharpless as FDA Commissioner
Letter of support for proposal on $0 copays for biosimilars
Comments on Sec 1557 of ACA to ensure coverage regardless of race, color, national origin, sex, disability and age
Letter of support for the Protecting Access to Medicare Act
Letter of support to House and Senate sponsors of bills banning smoking on VHA campuses
Letter to members of Congress supporting limiting the access of flavored e-cig products – Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act)
Comment letter on IPPS rule for CAR-T therapy
Letter to OMB with considerations for cancer patients in their selection of new inflation index
Letter to OMB with considerations for cancer patients in their selection of new inflation index
Letter of Support for the Public Health Funding Restoration Act which restores critical funding for public health and prevention research
Rule on Accumulators in the 2020 Notice of Benefit and Payment Parameters
Group statement of support for ending HPV-associated cancers
Letter to Ways and Means and Energy and Commerce Committees, supporting the removal of the 5% coinsurance requirement for Medicare Part D catastrophic coverage plans
Comments to HELP committee regarding Senators Alexander and Murray’s plan to reduce health costs
Letter of support for amending the Patent Act to prevent patents on human genes
Sign-on Letter to Protect Patient Access to Genetic Tests
Letter endorsing Henrietta Lacks Enhancing Cancer Research Act of 2019
Letter of support for the Stopping the Outrageous Practice (STOP) of Surprise Bills Act of 2019
Letter endorsing the CLINICAL TREATMENT ACT
Letter to the administration seeking exemption for the FDA in the proposed rule for Office of Management and Budget Office guidance update
Letter to Congresswoman Debbie Wasserman Schultz, applauding her support of the Protecting Access to Lifesaving Screening (PALS) Act and asking for an extension on the provisions of the Act, which would cover mammograms for women ages 40-49 at no cost.
Letter to President Trump and Senators Mitch McConnell (Majority Leader) and Chuck Schumer (Minority Leader) and Representatives Nancy Pelosi (Speaker of the House) and Kevin McCarthy (Minority Leader), urging them to open the government to ensure that the FDA can continue monitoring products for safety and efficacy, as well as reviewing applications for cancer treatments.
Members of Congress, led by Representatives Terri Sewell (D-AL-07) and Dan Young (R-IO-03), send letter to HHS Secretary Alex Azar, urging the continuation of co-testing for cervical cancer screening.
Letter to Senator Orrin Hatch (Chairman, U.S. Senate Finance Committee), Senator Ron Wyden (Ranking Member, U.S. Senate Finance Committee) regarding comments on the Graham-Cassidy-Heller-Johnson legislation to amend the Affordable Care Act
Comments on the new draft Cervical Cancer Screening Guidelines from the United States Preventive Services Task Force.
Letter to senators on need to prioritize prevention in Better Care Reconciliation Act.
Letter to congressional leadership on the importance of prioritizing preventive health coverage during consideration of changes to the Affordable Care Act.
Letter to congressional leadership strongly objecting to potential privatization of Medicare.
Comments in support of CMS Proposal for HBV Screening.
Letter to Senator Jeff Merkley thanking him for introducing the Medical Debt Relief Act, S. 2592. This bill would clear settled medical debt from credit reports and institute a 180-day reporting requirement for medical debt to credit agencies.
Letter to the Food and Drug Administration regarding recent regulations banning minors from using sunlamp products, and requiring adults visiting an indoor tanning facility to be properly informed of the risks involved.
Letter to Mitchell Zeller (Director, Center for Tobacco Products, U.S. Food and Drug Administration) urging the FDA to review and regulate new tobacco products, particularly those seemingly marketed to a younger audience, as required by the Family Smoking Prevention and Tobacco Control Act of 2009.
Letter to Senator Orrin Hatch (Chairman, U.S. Senate Finance Committee), Senator Ron Wyden (Ranking Member, U.S. Senate Finance Committee), Senator Johnny Isakson (Co-Chair, U.S. Senate Chronic Care Working Group), and Senator Mark Warner (Co-Chair, U.S. Senate Chronic Care Working Group) thanking them for consideration of care and payment for chronic conditions, for addressing cancer as a chronic condition, and comments on the Working Group’s policy proposals.
Letter to Senator Orrin Hatch (Chairman, U.S. Senate Finance Committee), Senator Ron Wyden (Ranking Member, U.S. Senate Finance Committee), Senator Johnny Isakson (Co-Chair, U.S. Senate Chronic Care Working Group), and Senator Mark Warner (Co-Chair, U.S. Senate Chronic Care Working Group) thanking them for consideration of care and payment for chronic conditions, for addressing cancer as a chronic condition, and comments on the Working Group’s policy proposals.
Letter to Senator Orrin Hatch (Chairman, U.S. Senate Finance Committee), Senator Ron Wyden (Ranking Member, U.S. Senate Finance Committee), Senator Johnny Isakson (Co-Chair, U.S. Senate Chronic Care Working Group), and Senator Mark Warner (Co-Chair, U.S. Senate Chronic Care Working Group) thanking them for consideration of care and payment for chronic conditions, for addressing cancer as a chronic condition, and comments on the Working Group’s policy proposals.
Letter to Senator Orrin Hatch (Chairman, U.S. Senate Finance Committee), Senator Ron Wyden (Ranking Member, U.S. Senate Finance Committee), Senator Johnny Isakson (Co-Chair, U.S. Senate Chronic Care Working Group), and Senator Mark Warner (Co-Chair, U.S. Senate Chronic Care Working Group) thanking them for consideration of care and payment for chronic conditions, for addressing cancer as a chronic condition, and comments on the Working Group’s policy proposals.
Letter to Senator Mitch McConnell (U.S. Senate Majority Leader), Senator Harry Reid (U.S. Senate Minority Leader), Representative Paul Ryan (Speaker of the U.S. House of Representatives) and Representative Nancy Pelosi (U.S. House of Representatives Minority Leader) urging them to include the Protect Access to Lifesaving Screenings (PALS) Act in the budget omnibus legislation. The PALS Act would but a moratorium on the U.S. Preventive Services Task Force’s recommendations on mammograms, maintaining access with no cost-sharing to annual mammograms above the age of 40.
Letter to Senator Lamar Alexander (Chairman, U.S. Senate HELP Committee), Senator Patty Murray (Ranking Member, U.S. Senate HELP Committee), Representative John Kline (Chairman, U.S. House of Representatives Education and Workforce Committee) and Representative Bobby Scott (Ranking Member, U.S. House of Representatives Education and Workforce Committee) supporting the inclusion of the Physical Education Program (PEP) in the Every Child Achieves Act.
Letter to Andy Slavitt (Acting Administrator, Centers for Medicare & Medicaid Services) regarding the Merit-Based Incentive Payment System and Alternative Payment Models. The letter urges CMS to consider, rather than over-utilization of services, targeted, proper utilization of services, and for any Alternative Payment Models to include consideration of payment for planning and coordination of care between doctors and patients.
Letter to Sylvia Burwell, Secretary of Health and Human Services, regarding the Affordable Care Act’s Non-Discrimination Proposed Rule. The letter urges HHS to more strictly define what constitutes non-discrimination in ACA plans, and to enforce the non-discrimination provisions of the Act.
Letter to Sylvia Burwell, Secretary of Health and Human Services, regarding the U.S. Preventive Services Task Force’s recommendation for low dose CT screening for lung cancer. The letter supports the “B” rating, and the decision by the Centers for Medicare and Medicaid Services to require coverage of low dose CT screening, but urges all relevant departments to educate the public about their access to screening.
Letter to Senator Lamar Alexander (Chairman, U.S. Senate HELP Committee) and Senator Patty Murray (Ranking Member, U.S. Senate HELP Committee) supporting the nomination of Dr. Robert Califf as the Commissioner of the Food and Drug Administration.
Letter to Congressman Fred Upton, Congresswoman Diana DeGette, and Congressman Frank Pallone regarding 21st Century Cures. The letter is a thank you for including certain provisions in the legislation, particularly the NIH Innovation Fund, which will provide the NIH with $10 billion of mandatory funding over five years and will help to ensure that the current momentum in research is not hindered by potential budget limitations.
Letter to Congressman Michael Burgess and Congresswoman Diana DeGette expressing support for the Preventive Health savings Act. This bill will expand the “scoring” window from 10 to 30 years in order to demonstrate the value of prevention and wellness-focused policies.
Letter to Congresswoman Renee Ellmers and Congressman Steve Israel regarding support for H.R. 1416, the Cancer Patient Protection Act of 2015. The letter thanks the members specifically commenting on the importance of the legislation as an important step in ensuring patients, especially Medicare beneficiaries, have access to community-based medical care by temporarily removing the application of the Medicare sequester cuts on Part B drugs while gathering additional research to determine sequestration’s effect on patient access.
Letter to the president of lululemon athletica regarding their reusable shopping bags. The bags say, “Sunscreen absorbed into the skin might be worse for you than sunshine. Get the right amount of sunshine.” The letter asks lululemon to replace this incorrect message with something more appropriate that promotes healthy behaviors.
Letter in support of the five-year $10 billion NIH Innovation Fund included in the second draft of the 21st Century Cures legislation.
Letter to Congressman John Carney and Congressman Andy Barr thanking them for the introduction of the Medical Debt Relief Act of 2015.
Letter endorsing Removing Barriers to Colorectal Cancer Screening Act (H.R. 1070 and S. 2348).
Letter to President Obama regarding the FDA timeline to finalize the regulation to extend FDA authority over all unregulated tobacco products. Specifically, the letter communicated that the regulation needs to be quickly finalized.
Letter to Congresswoman Cathy McMorris Rodgers expressing support for the Cancer Care Payment Reform Act of 2015.
National Coalition for Cancer Research
Letter to Congressman Fred Upton (Chair, House Committee on Energy and Commerce) and Congresswoman Diana DeGette regarding the 21st Century Cures initiative. Specifically, the letter focuses on increased resources for NIH and FDA, surrogate endpoint qualification and utilization, expanded access, clinical research modernization and centralized IRBs, and the NIH research strategic investment plan.
Letter to Members of Congress regarding support for the Fitness Integrated with Teaching Kids (FIT Kids) Act which would help children obtain a head start on healthy life by providing regular, quality physical education. The letter also encourages restoration of proper funding levels to the physical education program.
Letter to House and Senate appropriators regarding FY2016 appropriations legislation. Specifically, NCCR requested at least $32 billion for the National Institutes of Health (NIH) and a proportional percentage increase for the National Cancer Institute (NCI).
Letter to Members of Congress supporting the Genetic Information Nondiscrimination Act (GINA) and the Americans with Disabilities Act (ADA). The letter also opposes provisions within the Preserving Employee Wellness Programs Act (S.620/H.R.1189) that would allow employers to inquire about employees’ private genetic information or medical information unrelated to their ability to do their jobs, and penlize employees who choose to keep that information private.
Cancer Leadership Council
Letter to Congressman Fred Upton (Chairman, House Committee on Energy and Commerce) and Congresswoman Diana Degette regarding the January 2015 discussion draft “21st Century Cures Act.”
One Voice Against Cancer
Letter to Congressman Hal Rogers (Chairman, House Committee on Appropriations), Congresswoman Nita Lowey (Ranking Member, House Committee on Appropriations), Senator Thad Cochran (Senate Committee on Appropriations), and Senator Barbara Mikulski (Ranking Member, Senate Committee on Appropriations) regarding the FY 2016 Labor-HHS-Education appropriations bill. Specifically, the letter focuses on increased funding of $33 bilion for that National Institutes of Health including $5.4 billion for the National Cancer Institute.
One Voice Against Cancer
Letter to Congressman Fred Upton (Chairman, House Committee on Energy and Commerce) and Congresswoman Diana Degette regarding the January 2015 discussion draft “21st Century Cures Act.”
One Voice Against Cancer
Letter to Congressman Hal Rogers (Chairman, House Committee on Appropriations), Congresswoman Nita Lowey (Ranking Member, House Committee on Appropriations), Senator Thad Cochran (Senate Committee on Appropriations), and Senator Barbara Mikulski (Ranking Member, Senate Committee on Appropriations) regarding the President’s FY 2016 budget. Specifically, the letter focuses on the proposed cutes to cancer prevention and early detection programs within the Centers for Disease Control and Prevention.
One Voice Against Cancer
Letter to Senator Dick Durbin expressing gratitude for his introduction of the American Cures Act (S. 289).
Cancer Innovation Coalition Letter to Congressman Fred Upton (Chairman, House Committee on Energy and Commerce) and Congresswoman Diana Degette regarding the January 2015 discussion draft “21st Century Cures Act.”
Healthcare Leadership Council
Letter to Congress urging a repeal of the Independent Payment Advisory Board (IPAB) in order to protect Medicare beneficiaries’ access to quality healthcare.
National Osteoporosis Foundation
Letter to Congress encouraging support of the Medicare Part D non-interference provision. The letter was written in response to recent proposals to change Medicare Part D.
National Health Council
Letter to the House Committee on Energy and Commerce expressing gratitude for inclusion of the Dormant Therapies Act in the 21st Century Cures discussion draft bill.
Letter to the Office of Management and Budget and Congress regarding President Obama’s FY16 budget proposal. Specifically, the letter opposes cuts to the Centers for Disease Control and Prevention’s (CDC) cancer screening programs.
Letter to Congress opposing H.R. 662, legislation that would make exempt many cigars from regulation under the Family Smoking Prevention and Tobacco Control Act. The letter support the FDA retaining oversight authority over all tobacco products, including all cigars.
Urology Policy Forum
Letter to Congress regarding support for Con. Res., The Supporting Quality of Life for Prostate Cancer Patients which addresses the importance of reconstructive urological surgical treatments that utilize medical devices.
One Voice Against Cancer
Letter to Congresswoman Rosa DeLauro, Congressman Brian Higgins, Senator Barbara Mikulski, and Senator Benjamin Cardin regarding the Advancing Biomedical Research Act. Specifically, the letter expressed OVAC’s support for the legislation and thanked the Members for their efforts to restore investment in the National Institutes of Health (NIH).
Letter to Congressman Fred Upton regarding the 21st Century Cures legislation. Specifically, the letter encourages the committee to include the Patients’ Access to Treatment Act (PATA) language in the bill.
Cancer Leadership Council
Letter to Margaret Hamburg (Commissioner, U.S. Food and Drug Administration) regarding FDA-2011-D-0360, Framework for Regulatory Oversight of Laboratory Developed Tests. Specifically, the letter supports the risk-based approach to the regulation of LDTs.
Letter to Francis Collins (Director, National Institutes of Health) regarding the Draft NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research. Specifically, the letter supports a single IRB in an effort to reduce duplication and inefficiency.
Letter to Sylvia Burwell (Secretary, U.S. Department of Health and Human Services) regarding the new product provisions of the Family Smoking Prevention and Tobacco Control Act to products the U.S. Food and Drug Administration proposes to deem subject to its authority. Specifically, the letter focuses on the premarket review process for new tobacco products and the importance maintaining the orignal grandfathering date of February 15, 2007.
Letter to Senator Lamar Alexander and Senator Patty Murray regarding the Elementary and Secondary Education Act (ESEA). Specifically, the letter addresses Title IV and support the inclusion of physical education and health education as key components of the draft legislation.
Letter to Congress calling for an end to sequestration that is balanced, recognizes the impacts that austerity has already had on Americans, and that ensures that any relief from sequestration is the same, dollar-for-dollar, on both the defense and non-defense portions of the budget.
Letter to Congressman Fred Upton (Chairman, House Energy and Commerce Committee), Congressman Frank Pallone (Ranking Member, House Energy and Commerce Committee), Congressman Joe Pitts (Chairman Subcommittee on Health, Energy and Commerce Committee), Congressman Gene Green (Ranking Member, Subcommittee on Health, Energy and Commerce Committee), and Congresswoman Diana Degette (Member, House Energy and Commerce Committee) regarding the 21st Century Cures legislation and the potential inclusion of language to waive Medicare beneficiary coinsurance for a screening colonoscopy that involves removal of a polyp during the screening encounter.
Letter to the National Association of Insurance Commissioners Regulatory Framework (B) Task Force regarding the Health Benefit Plan Network Access and Adequacy Model Act.
Letter to Sylvia Burwell (Secretary, U.S. Department of Health and Human Services) regarding the Draft 2016 Letter to Issuers in the Federally-Facilitated Marketplaces
Letter to Tamara Syrek Jensen (Director, Coverage and Analysis Group, Center for Medicare and Medicaid Services) regarding the proposed National Coverage Determination for Lung Cancer Screening with Low Dose Computed Tomography (CAG-00439N).
Letter to Tamara Syrek Jensen (Director, Coverage and Analysis Group, Center for Medicare and Medicaid Services) regarding the proposed decision memorandum for screening for colorectal cancer using Cologuard™—A Multitarget Stool DNA Test
Letter to Mitchell Zeller (Director, Center for Tobacco Products, U.S. Food and Drug Administration) regarding FDA-2014-N-0189, deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act.
The Prevent Cancer Foundation strongly urges all Members of Congress, particularly those on the Senate and House Committees on Appropriations, to support funding for the National Institutes of Health (NIH), National Cancer Institute (NCI) and Centers for Disease Control and Prevention (CDC) Division of Cancer Prevention and Control (DCPC) in the FY 2015 Labor-HHS-Education appropriations bill.
Letter to Marilyn Tavenner (Administrator, Centers for Medicare and Medicaid Services) regarding CMS-4159-P, Contract Year
2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (“protected classes” issue).
Letter to Senator Barbara Mikulski (Chairman, U.S. Senate Committee on Appropriations), Senator Richard Shelby (Ranking Member, U.S. Senate Committee on Appropriations), Congressman Harold Rogers (Chairman, U.S. House Committee on Appropriations), and Congresswoman Nita Lowey (Ranking Member, U.S. House Committee on Appropriations) urging Congress to make funding for the FDA a national priority.
Comments regarding proposed rule FDA-2011-N-0898; Permanent Discontinuance or Interruption of Manufacturing of Certain Drug or Biological Products
Letter to President Obama urging him to recognize March as “National Colorectal Cancer Awareness Month”
Letter in support of Senator Richard Blumenthal’s S.Res. 330 commemorating the 50th anniversary of the Surgeon General’s Smoking and Health Report
Letter to Margaret A. Hamburg (Commissioner of Food and Drugs, Food and Drug Administration) regarding guidance on the naming of biosimilar products and asking the FDA to support a system of distinguishable names for all biological medicines in order to uphold the critical principles of transparency in healthcare and promote accurate physician-patient communication.
Letter to Marilyn Tavenner (Administrator, Centers for Medicare and Medicaid Services) regarding the 2015 Letter to Issuers in the Federally-facilitated Marketplace (FFM).
Letter to Congresswoman Rosa DeLauro regarding expedited approval mechanisms to speed promising drugs to patients suffering from serious illness and life-threatening diseases.
Letter to Marilyn Tavenner (Administrator, Centers for Medicare and Medicaid Services) regarding CMS-4159-P, Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (aka the protected classes issue)
Letter to Marilyn Tavenner (Administrator, Centers for Medicare and Medicaid Services) regarding CMS-4159-P: Medicare Program Contract Year 2015 Policy and Technical Changes to Medicare Advantage and the Medicare Prescription Drug Benefit Programs
Letter to Congress urging examination of why more women and minorities aren’t involved in medical research
Letter to Senator Ron Wyden (Chairman, U.S. Senate Committee on Finance), Senator Orrin G. Hatch (Ranking Member, U.S. Senate Committee on Finance), Congressman Dave Camp (Chairman, U.S. House Committee on Ways and Means), & Congressman Sander Levin (Ranking Member, U.S. House Committee on Ways and Means) urging Congress to reconsider implications of repealing the Orphan Drug Tax Credit
Letter to Senator Barbara Mikulski (Chairman, U.S. Senate Committee on Appropriations), Senator Richard Shelby (Ranking Member, U.S. Senate Committee on Appropriations), Congressman Harold Rogers (Chairman, U.S. House Committee on Appropriations), and Congresswoman Nita Lowey (Ranking Member, U.S. House Committee on Appropriations) urging Congress to restore the FY15 302(b) funding allocations to the Labor, HHS, Education, and Related Agencies Appropriations Subcommittee to the FY2010 level of $163.6 billion.
Letter to Senator Ron Wyden (Chairman, U.S. Senate Committee on Finance) and Senator Orrin Hatch (Ranking Member, U.S. Senate Committee on Finance) commending the SGR Repeal and Medicare Provider Payment Modernization Act of 2014 (S. 2000)
Letter to Letter to Senator Barbara Mikulski (Chairman, U.S. Senate Committee on Appropriations), Senator Richard Shelby (Ranking Member, U.S. Senate Committee on Appropriations), Congressman Tom Harkin (Chairman, Labor, HHS, and Related Agencies Appropriations Subcommittee), and Congressman Jerry Moran (Ranking Member, Labor, HHS, and Related Agencies Appropriations Subcommittee) regarding the FY2015 Labor-HHS-Education appropriations funding request of $510 million to the CDC, $5.26 billion for NCI, and $251 million for nursing scholarships and loan repayment.
Letter to Patrick Conway (Deputy Administrator for Innovation and Quality, Chief Medical Officer, Centers for Medicare and Medicaid Innovation) regarding the Mitre Corporation Technical Expert Panel for Specialty Payment Models Opportunities and Design Initiative and Request for Information on Specialty Payment Model Opportunities
Letter to Senator Mark Pryor, Senator Roy Blunt, Congressman Robert Aderholt, and Congressman Sam Farr regarding concern with the inclusion of language in the Joint Explanatory Statement of the 2014 Consolidated Appropriations Act that would establish a waiver approval process for the 2014-2015 school year for any local educational agency that incurs increased costs in order to comply with the updated nutrition standards for schools breakfasts and the updated standards for snack foods and beverages sold in schools.
Letter to Congressman Rodney Frelinghyusen (Chairman, House Committee on Appropriations, Subcommittee on Defense) and Congressman Peter Visclosky (Ranking Member, House Committee on Appropriations, Subcommittee on Defense) regarding the FY2015 Defense Appropriations bill and support for the defense health research programs conducted within the Department of Defense (DoD).
Letter regarding Congressional efforts to intervene in the process of determining what foods are provided by the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).
Letter to Congress recognizing May as National Cancer Research Month and urging Members to fund NIH at $32 billion and NCI at $5.26 billion.
Letter to Senator Tom Harkin (Chairman, U.S. Senate Committee on Appropriations, Labor, HHS, and Education Subcommittee) and Senator Jerry Moran (Ranking Member, U.S. Senate Committee on Appropriations, Labor, HHS, and Education Subcommittee) encouraging FY2015 funding levels to include $32 billion for NIH and $5.26 billion for NCI.
Letter to Dr. Margaret Hamburg, Commissioner, Food and Drug Administration regarding revisions to the Nutrition and Supplement Facts labels and the Reference Amounts Customarily Consumed (RACCs) for certain food and beverage products.
Letter to Senator Richard Blumenthal and Congresswoman Rosa DeLauro expressing support for H.R. 2831/S.2342 (Stop Subsidizing Childhood Obesity Act) to amend the Internal Revenue Code to remove the tax deductibility of expenses for marketing foods of poor nutritional quality to children.
“I am (still) essential” letter to HHS Secretary Burwell to reduce barriers to care in qualified health plans. This letter was signed in coalition with 333 patient groups.
Letter to FDA Administrator Dr. Margaret Hamburg regarding food labeling: Serving sizes of foods that can reasonably be consumed at one-eating occasion and food labeling: revision of the nutrition and supplemental facts labels,
Letter to Senator Susan Collins, Senator Heidi Heitkamp, Representative Tom Latham, and Representative Mike McIntyre in support of S. 2210/H.R.1783, the School Food Modernization Act.
Letter to Marilyn Tavenner (Administrator, Centers for Medicare and Medicaid Services) regarding a potential exclusion in the Open Payments Program for indirect payments to voluntary health agencies
Letter to Dr. Patrick Conway (Acting Director, Centers for Medicare and Medicaid Innovation) regarding the Medicare Care Choices Model
Letter to Marilyn Tavenner (Administrator, Centers for Medicare and Medicaid Services) regarding CMS-1612-P, Revisions to Payment Policies Under the Physician Fee Schedule for CY2015
Letter to Tamara S. Syrek Jensen (Acting Director, Coverage and Analysis Group, Center for Medicare and Medicaid Services) regarding the national coverage analysis for lung cancer screening with low dose computed tomography (CAG-00439N)
Letter to Senator Debbie Stabenow thanking her for working to advance legislation to ensure patient access to community-based care.
Letter to Patrick Conway (Deputy Administrator for Innovation and Quality/Chief Medical Officer, Centers for Medicare and Medicaid Services) regarding the Oncology Care Model.
Letter to the Senate Finance Committee regarding support for the “Removing Barriers to Colorectal Cancer Screening Act.”
Letter to Congressman Hal Rogers, Congresswoman Nita Lowey, Senator Barbara Mikulski, and Senator Richard Shelby regarding funding for programs essential to the fight against cancer in FY 2015 appropriations.
Letter to Sylvia Burwell (Secretary, U.S. Department of Health and Human Services) regarding an extension on the Draft Guidance on Disclosing Reasonably Forseeable Risks in Research Evaluating Standards of Care.
Letter to House and Senate appropriators regarding the FY2015 budget, particuarly for the National Institutes of Health (NIH) and National Cancer Institute (NCI).
Letter to Sylvia Burwell (Secretary, U.S. Department of Health and Human Services) and Margaret A. Hamburg (Commissioner, U.S. Food and Drug Administration) regarding the draft guidance entitled “Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs).”
Letter to Marilyn Tavenner (Administrator, Centers for Medicare & Medicaid Services) regarding CMS-1612-FC the calendar year 2015 Medicare Physician Fee Schedule final rule. Specifically, the coalition focused on advanced care planning CPT codes.
Letter to Sylvia Burwell (Secretary, U.S. Department of Health and Human Services) regarding CMS-9944-P, Proposed Rule on Notice and Benefit of Payment Parameters for 2014. Specifically, REAP focused on essential health benefits, drug coverage, non-discrimination, transparency, and automatic re-enrollment.
Letter to Sylvia Burwell (Secretary, U.S. Department of Health and Human Services) regarding CMS-9944-P, Proposed Rule on Notice and Benefit of Payment Parameters for 2014. Specifically, the CLC on essential health benefits, prescription drug benefits, the exceptions process, formulary drug list transparency, prohibition on discrimination, network adequacy and cost-sharing requirements, habilitative and rehabilitative services for cancer patients, data collection, and quality improvement strategy.
Letter to Sylvia Burwell (Secretary, U.S. Department of Health and Human Services) regarding CMS-9944-P, Proposed Rule on Notice and Benefit of Payment Parameters for 2014. Specifically, the NHC focused on annual eligibility redeterminations, annual open enrollment period, provision of essential health benefits, collection of data to define essential health benefits, prescription drug benefits, prohibition on discrimination, cost-sharing requirements, network adequacy standards, essential community providers, plan variations, and quality improvement strategy.
